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The Human Silencing Hub (HUSH) complex is necessary for epigenetic repression of LINE-1
elements. We show that HUSH-depletion in human cell lines and primary fibroblasts leads to
induction of interferon-stimulated genes (ISGs) through JAK/STAT signaling. This effect is
mainly attributed to MDA5 and RIG-I sensing of double-stranded RNAs (dsRNAs). This
coincides with upregulation of primate-conserved LINE-1s, as well as increased expression of
full-length hominid-specific LINE-1s that produce bidirectional RNAs, which may form dsRNA.
Notably, LTRs nearby ISGs are derepressed likely rendering these genes more responsive to
interferon. LINE-1 shRNAs can abrogate the HUSH-dependent response, while over-
expression of an engineered LINE-1 construct activates interferon signaling. Finally, we show
that the HUSH component, MPP8 is frequently downregulated in diverse cancers and that its
depletion leads to DNA damage. These results suggest that LINE-1s may drive physiological
or autoinflammatory responses through dsRNA sensing and gene-regulatory roles and are
controlled by the HUSH complex.
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Throughout evolutionary history, the human genome hasbeen continuously bombarded with genome invasions,either from exogenous retroviruses that have infected the
germline, or from new waves of endogenous transposition1. This
process has led to up to two-thirds of our genome now consisting
of repetitive DNA2. Transposition is important to drive genome
innovation, and there is an increasing number of documented
cases where transposable elements (TEs) have been repurposed,
for example to act as enhancers or promoters, with functions in
pathogen defense3. Regulation of the mobile genome is critical to
maintain genome integrity, however, and this is largely achieved
through epigenetic silencing. For example, long interspersed
element-1s (LINE-1s) are targeted by histone deacetylation,
H3K9me3 and DNA methylation4–7. Recent data have revealed
that inactivation of epigenetic silencing, particularly in human
cancer cell lines leads to the reactivation of endogenous retro-
viruses and other TEs8–15. This is accompanied by activation of
cytosolic nucleic acid sensors of the innate immune system and
production of type I interferons (IFNα and IFNβ, reviewed in
ref. 16). Such activation can overcome resistance to checkpoint
blockade and promote anti-tumor immunity in mouse cancer
models14, although type I IFNs can worsen cancer progression
and disease outcome when they are constitutively produced17.
IFN production following treatment of colorectal or ovarian
cancer cells with pharmacological inhibitors of DNA methylation
appears to depend on double-stranded RNA (dsRNA) sensing
through the RIG-I-like receptors (RLRs), MDA5 (melanoma
differentiation factor 5) and RIG-I (retinoic acid-inducible gene I)
and activation of their downstream mitochondrial adaptor,
MAVS (mitochondrial antiviral signaling protein)8,13. Very little
is understood, however, about which classes of repetitive DNA
potentially produce RNA molecules that engage with the RLRs
and mediate cross-talk with innate and adaptive immunity, either
in physiological or disease contexts. Likewise, little is known
about which epigenetic pathways are involved in transcriptional
control of repetitive DNA in human adult tissues12,15 or in cancer
cells10,14. Notably, however, Alu elements that exhibit an inverted
repeat configuration in the genome have been identified to form
duplex RNA recognized by the dsRNA sensor MDA518–20 and
LINE-1 elements are implicated in IFN activation, including
through cGAS (cyclic GMP-AMP synthase) and STING-(stimu-
lator of IFN genes)-dependent DNA sensing21–24.
The human silencing hub (HUSH) complex was discovered as
a novel epigenetic complex responsible for position-effect var-
iegation of integrated transgenes in human cells25. It is associated
with H3K9me3-dense genomic regions, including the 3 prime
ends of zinc finger genes and functions to repress zinc finger
genes and ribosomal DNAs25–27. The HUSH complex partners
with the chromatin regulator MORC2, which contains a zinc
finger and an ATPase domain26. Mutations in MORC2 are
associated with neuropathies and these disease mutations have
been found to affect MORC2 structure and HUSH function28.
The HUSH complex has also been discovered to mediate epige-
netic silencing of murine leukemia virus through its recruitment
by NP220 to the viral DNA before its integration, thereby pre-
venting viral infection29. HUSH exerts some position-dependent
repression on HIV, which encodes accessory proteins that can
counteract HUSH repression, through mediating degradation of
HUSH complex components25,30,31.
We and others have recently demonstrated the HUSH complex
to be necessary to repress LINE-1 elements32–34. We showed that
the HUSH complex represses LINE-1s and co-regulated genes in
naïve mouse embryonic stem cells34 and is mainly required to
regulate the youngest species-specific LINE-1s32,34. Interestingly,
MORC2 exerts some binding specificity for full length LINE-1s33.
Here, we reasoned that HUSH-regulated LINE-1s with full-length
mRNAs and potentially intact ORFs may have been repurposed
to drive nucleic acid sensing in human adult tissues. We show
here that the HUSH complex negatively regulates the type I IFN
response in human cells through epigenetic regulation of LINE-1
elements. Furthermore, we provide evidence that young LINE-1s
produce bidirectional transcripts that could form dsRNA.
Results
The HUSH complex regulates type I IFN signaling. We asked
whether the HUSH complex regulates type I IFN induction and
responsiveness in human cells by employing shRNA-mediated
HUSH depletion in a HEK293 IFN reporter cell line. These cells
have been described before35,36 and harbor an integrated lenti-
vector expressing destabilized GFP under control of IFN-
stimulated response elements (ISRE), referred to as ISRE-GFP
(Fig. 1a). We verified by western blot or qRT-PCR that HUSH
components were depleted by day 4 post introduction of the
shRNAs (Fig. 1b) and found that the ISRE-GFP reporter becomes
activated at day 6 post shRNA addition (Fig. 1c). While depletion
of MPP8 led to a potent IFN response, periphilin (PPHLN1)-
depletion induced a significant but lesser response, and TASOR-
depleted cells only exhibited a minor shift in ISRE-GFP reporter
expression. Controls had no effect on the reporter (Fig. 1c and
Supplementary Fig. 1a). Interestingly, combining TASOR and
MPP8 depletions revealed that TASOR-depletion could partially
inhibit the endogenous IFN-stimulated gene (ISG) response
mediated by MPP8-depletion (Fig. 1d). However, induction of the
ISRE-GFP reporter was more potent in TASOR-depleted cells
compared to control cells each treated with IFN-β (Fig. 1e). This
suggests that TASOR-depleted cells are poised for innate immune
activation.
The HUSH complex controls type I IFN induction. We then
employed MPP8-depletion to pursue the mechanism further and
first verified that the ISRE-GFP reporter was activated upon
MPP8-depletion using additional MPP8 shRNAs (Supplementary
Fig. 1a). We confirmed that endogenous ISGs were induced upon
MPP8-depletion in three additional human cell lines: HeLa cells,
THP-1 cells (acute monocytic leukemia cell line) and untrans-
formed primary foreskin fibroblasts (HFFs) (Fig. 1f and Supple-
mentary Fig. 1b). Supernatant from MPP8-depleted 293 cells was
sufficient to activate the ISRE-GFP reporter cells in an IFN
bioassay (Fig. 1g) and MPP8-depletion led to an induction of
IFN-β itself, shown here by employing an IFN-β reporter cell line
in which GFP is driven by an IFN-β promoter36 and by IFN-β
ELISA (Fig. 1h, i). We found that expression of the ISRE-GFP
reporter was dependent on JAK/STAT signaling by employing a
JAK/STAT inhibitor (Fig. 1j and Supplementary Fig. 1c for the
endogenous response). PPHLN1-depletion led to a significant
induction of type I IFN and JAK/STAT-dependent ISG expres-
sion (Supplementary Fig. 1d–f), albeit to a lesser extent than
MPP8-depletion. Finally, an IFN bioassay revealed that IFN is
also produced by primary fibroblasts upon MPP8 or PPHLN1-
depletion (Fig. 1k). These data suggest that the HUSH complex
regulates the induction and response to type I IFNs.
The HUSH complex regulates genes involved in inflammation.
To understand the global phenotype of HUSH-depletion, we
performed total RNA-sequencing of primary fibroblasts. Results
for MPP8-depletion showed a clear upregulation of genes
involved in immunity and inflammation (Fig. 2a, b, dataset 1 in
the Source data file), including 204 ISGs, which typically function
in innate and adaptive immunity (employing a list we defined
before in ref. 15). Of the fraction that were not defined as ISGs, 16
were KZNFs in accordance with the known function of the
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HUSH complex in binding to and regulating KZNF genes25,26,33
and most of these were previously identified to be MORC2-
bound33 (Fig. 2b and Supplementary Fig. 2). Other upregulated
genes were enriched for roles in chromatin regulation, cell cycle
and DNA damage (Supplementary Fig. 3a–c). Of note, the IFN
and inflammatory gene signature upon MPP8-depletion was
reproduced in HeLa cells (Supplementary Fig. 3d). We used gene
set enrichment analyses to assess the phenotype observed upon
depletion of individual HUSH components in primary fibroblasts
(Fig. 2c, dataset 1 in the Source data file). TASOR-depleted
samples differed from MPP8 and PPHLN1 in their lack of an
activated IFN signature but overlapped in terms of TNF-α sig-
naling and G2M cell cycle checkpoint. This might indicate that
greater depletion of TASOR than that achieved here was required
to observe a more complete phenotype. Concordance between
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Fig. 1 The HUSH complex regulates the type I IFN response. a Diagram of IFN induction assay: HEK293 cells harbor an integrated IFN reporter expressing
destabilized GFP (dscGFP). ISRE: IFN-stimulated response elements; mCMV: minimal CMV promoter. GFP was assessed 6 days post shRNAs. b Western
blot and qRT-PCR to assess HUSH depletion day 4 post shRNAs. PPHLN1 mRNA normalized to GAPDH. N= 3 biologically independent samples with
technical qRT-PCR duplicates shown. c ISRE-GFP induction 6 days post shRNAs. N= 3 biologically independent experiments. Two-tailed unpaired t tests of
shRNAs vs. shControl: p= <0.0001 (shMPP8), p= 0.0372 (shPPHLN1) and p= 0.0466 (TASOR). d shMPP8 was combined with shTASOR or controls as
stated. qRT-PCR of endogenous ISG mRNA expression (GAPDH normalized). N= 3 biologically independent experiments with technical duplicates shown.
A two-tailed unpaired t test was used to compare shMPP8+ shControl to shMPP8+ shTASOR for CCL5 (p= 0.0021). e shTASOR or shControl-treated cells
were treated with IFN-β and ISRE-GFP measured 24 h later. N= 3 biologically independent experiments. P value: 0.0037 (two-tailed paired t test). MFI:
mean fluorescent intensity. f QRT-PCR of ISG expression (GAPDH normalization) 6 days post shRNAs (or 3 days in the case of HeLa cells). N= 3
biologically independent experiments with technical duplicates shown. Two-tailed paired t tests were used to compare controls to shMPP8 for CXCL10: p=
0.0473 (HeLa), p= 0.0229 (THP-1s) and p= 0.0084 (HFFs). g IFN bioassay: supernatants from shRNA-treated 293 cells were added to ISRE-GFP reporter
293 cells and GFP expression measured 24 h later. N= 4 biologically independent samples. P= 0.0240 (two-tailed paired t test). h 293 cells containing an
IFN-β-destabilized GFP reporter were transduced with the stated shRNAs and GFP measured 6 days later. N= 3 biologically independent samples. P=
0.0005 (two-tailed paired t test). i Supernatants were harvested 6 days post shRNAs and used for an IFN-β ELISA. N= 4 biologically independent samples.
P= 0.0023 (two-tailed paired t test). j 293 cells treated with shRNAs in the presence of the JAK/STAT inhibitor Ruxolitinib or DMSO (added from day 1)
were harvested for GFP FACS at day 6. N= 4 biologically independent samples. IFN-β ± Ruxolitinib served as a positive control. P= < 0.0001 (two-tailed
unpaired t test). k IFN bioassay: supernatants from shRNA-treated HFFs were added to ISRE-GFP reporter 293 cells and GFP expression measured 24 h
later. N= 3 biologically independent samples. Two-tailed paired t test p values: p= 0.0469 (shMPP8), p= 0.0320 (shPPHLN1). All data presented in this
figure show mean values ± SD except (b), which depicts mean values ± SEM.
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number of mutually-upregulated genes (Fig. 2d), which included
KZNFs for MPP8 and PPHLN1 but not TASOR (Fig. 2e). Genes
uniquely up or downregulated in TASOR-depleted cells are
depicted in Fig. 2f and interestingly, several of these (SQSTM1
and ACSS1) have immunomodulatory roles37,38.
MPP8-depletion is accompanied by RLR-dependent RNA
sensing. There is mounting evidence that epigenetic pathways
prevent TEs from nucleic acid sensing through RLRs, particularly
in cancer cells8,10,13,14. We detected expression of components of
the RLR-signaling pathway, MDA5, RIG-I, and MAVS in all cell
lines in which we had observed an IFN response upon HUSH-
depletion (Fig. 3a). cGAS, in contrast, was not detected in 293
cells following IFN-β treatment, although it was readily expressed
in THP-1 cells in which it was upregulated upon IFN-β treatment
(Fig. 3a). We confirmed that the IFN response was MAVS-
dependent using shRNA depletion of MAVS in ISRE-GFP and
IFN-β GFP 293 reporter cells and we verified that MAVS-
depleted cells could no longer react to stimulation with poly(I:C),
Fig. 2 The HUSH complex regulates genes involved in inflammation. Primary fibroblasts (HFFs) were treated with shRNA vectors, and RNA harvested
6 days later for total RNA-sequencing. N= 6 biologically independent experiments. a MA plot showing results of differential expression analysis, where
significantly differentially expressed genes (log2 fold change > 1 and a p-adjusted value < 0.05 after Benjamini–Hochberg multiple testing correction of
Wald test p-value of shMPP8/shControl) have been highlighted in dark cyan and ISGs are shown in purple. See dataset 1 in Source data for all exact p
values. Example upregulated ISGs are labeled as well as HUSH components (of which MPHOSPH8/MPP8 is downregulated). b Venn diagram showing
overlap of ISGs (list defined in ref. 15) with genes upregulated in MPP8-depleted samples. Upregulated KZNFs are listed. See also Supplementary Fig. 2 for
MORC2 binding data using public ChIP data33. c Total RNA-seq data were generated for samples depleted for each HUSH component vs. shControls (n= 3
biologically independent experiments and data are represented as gene set enrichment analyses using fgsea, where nominal p-values were calculated for
1000 permutations and corrected for multiple-testing using the Benjamini–Hochberg method). d Venn diagram showing overlap of genes upregulated in
each HUSH-depletion. e Comparison of number and overlap of KZNFs upregulated in HUSH-depleted cells. f Significantly differentially-expressed genes
unique to TASOR-depleted samples are listed.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19170-5
4 NATURE COMMUNICATIONS |         (2020) 11:5387 | https://doi.org/10.1038/s41467-020-19170-5 | www.nature.com/naturecommunications
a dsRNA analog (Fig. 3b). To dissect whether MAVS signaling
was mainly dependent on RIG-I or MDA5, we employed
CRISPR/Cas9-generated knockout 293 cells for either or both
dsRNA sensors. Results showed that the response is dependent on
MDA5 with a contribution from RIG-I (Fig. 3c). We verified by
western blot that expression of MDA5 and RIG-I were detected in
the expected cells upon their treatment with IFN-β (Fig. 3d). Note
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Fig. 3 MPP8-depletion is accompanied by RLR-dependent RNA sensing. a Western blots on extracts from stated cells treated ± IFN-β for 24 h. N= 2
independent blots with one representative blot shown. b 293 cells were co-transduced with shControl or shMPP8 plus shMAVS or a control vector of the
same backbone (hygromycin) and GFP was measured on day 6 (left). MAVS depletion was verified using polyI:C, added 24 h before FACS (middle).
Summary data shown for experiments in ISRE-GFP and IFN-β-GFP reporter cells (right, n= 3 biologically independent samples). P= 0.0372 (one-tailed
paired t test). MFI: mean fluorescent intensity. c Left: qRT-PCR expression of endogenous ISGs in the stated shRNA-treated 293 cell lines at day 6 (GAPDH
normalized). N= 4 biological independent experiments with technical duplicates shown. CCL5 and CXCL10 were measured in all experiments while the
other 3 ISGs were measured in 3 of the experiments. One-tailed paired t tests showed expression of all ISGs was significantly lower in MDA5−/− cells and
double knockout (DKO) cells than in wildtype (WT) controls. IFIT1: p= 0.0063 (MDA5−/−), p= 0.0026 (DKO); IFIT2: 0.0007 (MDA5−/−), 0.0019
(DKO); CCL5: 0.0002 (MDA5−/−), 0.0028 (DKO); CXCL10: 0.0001 (MDA5−/−), 0.0007 (DKO); MxA: 0.0427 (MDA5−/−), 0.0423 (DKO).
Expression of CCL5, CXCL10, and MxA was significantly decreased in RIG-I−/− cells compared to controls. CCL5: p= 0.0183; CXCL10: p= 0.0372; MxA:
p= 0.0139. Right: MPP8 depletion efficiency summary (n= 4 biologically independent experiments with technical duplicates shown. d Western blots on
extracts from cell lines from c treated ± IFN-β for 24 h. N= 2 independent blots with one representative blot shown. e Left: stated knockout or control (WT)
THP-1 reporter cell lines were treated with shRNAs and assayed for secreted Lucia luciferase (driven by IFIT-2) 6 days later. N= 4 biologically independent
experiments. Luciferase readings were normalized to background values in shControl-treated cells. P= 0.0003 (one-tailed paired t test). Right: western blots
on extracts from stated cells. N= 3 independent blots with one representative blot shown. f 293 cells were treated with shRNAs and fixed 6 days later for
intracellular staining with dsRNA antibodies, J2/K1 or control antibodies. N= 3 biologically independent samples. Two-tailed unpaired t test p values=
0.0166 (shMPP8 vs. shControl for K1 Ab); 0.0048 (shMPP8 vs. shControl for J2 Ab); 0.0212 (shMPP8+ J2 Ab ± dsRNase). All data presented in this
figure show mean values ± SD.
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control cells, potentially to compensate for RIG-I loss, while in
MDA5 knockout cells, RIG-I expression is low, possibly con-
tributing to the low IFN response in these cells upon MPP8-
depletion (Fig. 3d). Importantly, we verified that all wildtype and
knockout cell lines could mount a response to IFN-β treatment by
measuring the induction of IFIT1 and ISG15 (Fig. 3d).
We then asked if the cGAS/STING pathway was necessary for
IFN signaling upon MPP8-depletion in a cell line efficient for
DNA sensing, (Fig. 3a). For this, we employed commercially-
available THP-1 cells that stably express an IFIT2-responsive
luciferase reporter that are either knockouts for the DNA sensors
cGAS or STING, or for the IFN type-I receptor (IFNAR). The
observed IFN response was independent of cGAS/STING but
dependent on signaling through the type I IFN receptor, as
expected (Fig. 3e). Knockout of DNA sensors was verified by
western blot and functionally by stimulation with agonists (Fig. 3e
right and Supplementary Fig. 3e). Since results suggested that the
IFN response is dependent on dsRNA (Fig. 3b–d), we tested
whether we could detect dsRNA in MPP8-depleted cells by
employing antibodies (J2 and K1) that recognize dsRNA. DsRNA
was apparent in MPP8-depleted cells and the signal was
abrogated by pretreatment with the long dsRNA-specific
endoribonuclease, RNase III (Fig. 3f).
MPP8-depletion results in overexpression of LINE-1s and
LTRs. We and others previously showed that the HUSH complex
mediates epigenetic repression of LINE-1 elements32–34, and we
hypothesized that LINE-1 RNAs could be driving the IFN
response in MPP8-depleted cells. However, the HUSH complex
also represses MLV29 and potentially also HIV25,30,31. We,
therefore, first verified that our shRNA lentivector itself was not
necessary to drive the ISG response, by using siRNAs against
MPP8 to show that there is still induction of the ISRE-GFP
reporter (Fig. 4a). This suggested that the ligand driving the
response is endogenous.
We then verified that LINE-1s are overexpressed in MPP8-
depleted cells by LINE-1 ORF1-protein western (Fig. 4b). We
employed our RNA-sequencing data to determine which TE
subfamilies are differentially expressed in MPP8-depleted cells
(using TEtranscripts: TEcount tool39). We found mainly primate-
specific LTR (long terminal repeat) families of between 20 and 50
million years old to be derepressed, including ERV9 and HERVH
(Fig. 4c and Supplementary Fig. 4a, b, dataset 2 in the Source data
file). We then mapped which precise TE loci were affected in the
human genome by assigning uniquely-mapping reads to the
genome and intersecting results with coordinates of TEs (using
RepeatMasker annotation) and we found mainly LINE-1s, SINEs,
and LTRs were upregulated (Fig. 4d, e and Supplementary Fig. 4b,
dataset 3 in the Source data file). Although numerous LINE-1 loci
were overexpressed, they were not significantly upregulated at the
subfamily level using TEtranscripts (dataset 2 in the Source data
file). This suggests that LINE-1 upregulation is context-depen-
dent, consistent with the known role of HUSH in regulating TEs
in introns of genes33,34. Employing available HUSH-binding data
revealed that LINE-1s rather than LTRs were likely direct binding
targets (Fig. 4d, e and Supplementary Fig. 4b). We highlighted the
top five LINE-1 subfamilies in orange containing the most
upregulated and most HUSH-bound copies, respectively (Fig. 4d,
top and bottom), which spanned families between 12 and 100
million years old.
We next looked at the distance of upregulated LINE-1s and
upregulated LTRs to the transcriptional start sites (TSS) of
upregulated ISGs, hypothesizing that these TEs may directly
regulate these genes (Fig. 4f). The LTRs were significantly closer
to ISGs than to random genes suggesting that they may have been
co-opted to act as promoters or enhancers for these genes,
thereby contributing to the increased IFN-responsiveness in
HUSH-depleted cells (Fig. 1). The LINE-1s were not significantly
close to the TSS of ISGs but were enriched within long noncoding
RNAs (Supplementary Fig. 4c).
L1PA1 and L1PA2 are a potential source of dsRNA. We and
others have previously shown that HUSH represses young
species-specific LINE-1s, albeit mainly in early development32–34.
We, therefore, focused on the hominid-specific families, L1PA1
(also called L1HS) and L1PA2, which we noticed were expressed
bidirectionally and are known to be MORC2-bound at the 5′
UTR33. While L1PA1 is difficult to map at the locus level, due to
its high copy number and integrants being mostly identical, we
mapped RNA-sequencing reads to the L1PA1 consensus
sequence and found that there is significantly more production of
sense and antisense strands in MPP8-depleted cells (Fig. 4g). This
was also the case for L1PA2, which we show is bidirectionally-
expressed as well (Supplementary Fig. 4d). Importantly, in an
unbiased approach, we also identified regions in the genome with
the highest (top 15%) overlapping expression in both strands and
found that L1PA1 was the most overrepresented TE in those
regions, followed by L1PA2. Bidirectional LINE-1s (199 L1PA1
and 74 L1PA2) were full-length with a median length of around 6
kb (Supplementary Fig. 4e) and could potentially pair in cis or
trans to produce dsRNAs to accumulate in the cytoplasm.
Example bidirectionally-transcribed LINE-1s and upregulated
primate-conserved LINE-1s are shown (Fig. 4h, i, Supplementary
Fig. 5). Of note, bidirectional L1PA1 loci were 100% identical to
the ORF1 protein probed for by western blot, suggesting that we
are detecting L1PA1 expression by western (Fig. 4b, dataset 4 in
the Source data file).
LINE-1s regulate the type I IFN response. Data indicated that
the striking IFN response observed upon MPP8-depletion could
result from a mixture of components, including LINE-1 RNAs,
effects of ZNF transcription factors and unveiled LTRs (Figs. 2, 4
and Supplementary Fig. 6a). We focused on the role of LINE-1
RNAs: We first determined that reverse transcription was not
necessary to drive IFN by using reverse transcriptase inhibitors
that are effective against LINE-1 RNA and HIV, used here as a
positive control (Supplementary Fig. 6b). In contrast, over-
expression of ZNF91 and to a lesser extent ZNF93, which are
transcriptional repressors of SVA and LINE-1 (L1PA4) elements,
respectively40 and their co-repressor, KAP1 could partially reduce
the IFN response (Supplementary Fig. 6c). The modest effect of
ZNF93 might relate to the fact that it does not target young
LINE-1s, which may be the main source of dsRNA (Fig. 4g and
Supplementary Fig. 4d). We, therefore, designed a series of LINE-
1 shRNAs and tested them to ascertain if any could inhibit the
HUSH-dependent IFN response. We found that two hairpins
could partially block the ISRE-GFP reporter response, one
designed on the 5’UTR of L1PA1 using the consensus sequence,
and one designed on L1PA4 ORF2 using an MPP8-bound ele-
ment33 (see Fig. 5a). Additionally, we designed a hairpin against
MOV10, an RNA helicase thought to sequester LINE-1 RNA
away from MDA524,41. This hairpin led to an augmentation of
the IFN response, further suggesting that endogenous LINE-1
RNAs can mediate MDA5-sensing (Fig. 5a). We verified that the
LINE-1 shRNAs could also block the endogenous ISG response
(Fig. 5b). The shL1PA4 hairpin induced a detectable decrease in
global expression of L1PA2-4 RNA by qRT-PCR (Fig. 5c). The
L1PA1-2 hairpin recognized L1PA1s and L1PA2s equally (584
LINE-1 integrants, of which 288 were L1PA1 and 271 were
L1PA2). Using primers that could detect 76 L1PA2s targeted by
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this hairpin, we could show a decrease in LINE-1 upregulation
upon MPP8-depletion (Supplementary Fig. 6d).
We next employed public RNA-sequencing data of genes
induced upon expression of an engineered full-length active
L1PA1 construct (in RPE cells)21 to see if there was
any concordance with genes upregulated in our MPP8-
depleted HFF cells. The L1PA1 construct, which was codon-
optimized, was doxycycline-induced for 3 days and the
response was compared to an induced luciferase control to
obtain a list of L1-induced genes21. There was an overlap of 114
genes, which included 49 ISGs. This was highly significant
when compared to the overlap of randomized gene sets of the
same number as the number of MPP8-repressed genes (Fig. 5d).
Finally, we could show that transfection of an engineered full-
length L1PA1 construct was sufficient for induction of the
ISRE-GFP reporter in 293 cells (Fig. 5e). These data taken
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MPP8 is frequently downregulated in cancers. Given the
emerging role of epigenetic regulators as therapeutic targets in
cancer42,43, we tested if MPP8 is differentially expressed in the
context of this group of diseases. For this, we used the human
cancer genome atlas (TCGA)44 data, focusing on tissues for
which there is also available expression data in healthy control
samples from GTEx45, as well as matched TCGA controls. MPP8
was significantly downregulated in 10 out of 15 diverse human
cancers as compared to both controls (Fig. 6a). We did not see the
same trend for TASOR or PPHLN1 (Supplementary Fig. 6e),
which may relate to the more striking phenotype observed of
MPP8 depletion (Figs. 1 and 2). To gain insight into whether
MPP8 depletion in cancers is associated with an IFN signature,
we divided cancers by recently-defined immune subtype cate-
gories17, plotting MPP8 expression levels. We found that MPP8
was most significantly downregulated in cancers with an IFN-γ
dominant C2 immune subtype (Fig. 6b). This included high
expression of the ISGs, CCL5 and CXCL10.
Given the observed trend across most cancer types to
downregulate MPP8, we considered that one of the selective
advantages this could confer could be a decreased capacity to
repair DNA, also hinted at by the secondary genes upregulated
upon MPP8 depletion, which are enriched for DNA damage, cell
cycle and chromatin maintenance pathways (Supplementary
Fig. 3a–c). This, together with the known risk of active LINE-1
elements in inducing DNA damage and compromising DNA
repair21,46–48, led us to examine if depleting MPP8 in 293 cells
was sufficient to lead to DNA damage. We observed that at
baseline, MPP8-depleted cells display more damage compared to
control cells, as measured by γH2AX staining, and are also
compromised in DNA repair following etoposide-induced
damage (Fig. 6c). We observed the same trend in HeLa cells
(Supplementary Fig. 6f).
Discussion
Here we reveal that the HUSH complex controls type I IFN
signaling in human cells and that the mechanism involves dsRNA
sensing by MDA5 and RIG-I. We link this cell-intrinsic innate
immune response partly to LINE-1 elements, which become
derepressed at the RNA and protein level following HUSH-
depletion. Surprisingly, we find that full-length hominid-specific
LINE-1 elements, including L1PA1 and L1PA2 produce bidirec-
tional transcripts. This suggests that young LINE-1s are a natural
source of dsRNAs of 6Kb in length, ideal candidates for recog-
nition by the long dsRNA sensor, MDA5, which detects dsRNA
greater than 2 kb in length49. These RNAs were transcribed in
control cells and increased in abundance in MPP8-depleted cells.
We speculate that these LINE-1 dsRNAs may be chromatin-
tethered in control cells and only become cytoplasmic and
available for MDA5-sensing upon HUSH-depletion. Of note, we
have focused on LINE1s in this study but there are likely many
other potential sources of dsRNAs.
Of interest, we identify an increase in LINE-1 mRNAs derived
from ancient primate-conserved LINE-1 loci in MPP8-depleted
cells. These conserved LINE-1s may have evolved beneficial roles
in host gene regulation since many are positioned within introns
of genes as noted before33,34. Interestingly, these conserved LINE-
1s are also enriched in long non-coding RNAs, which can derive
from LINE-1s50. LINE-1 elements originated more than 160
million years ago51 and have co-evolved with mammals to regulate
genes: LINE-1 and LINE-2 elements have been repurposed in the
formation of chimeric transcripts driven by LINE-1 antisense
promoters52, in chromatin-associated non-coding RNAs53 and in
exonization events, including into immunoregulatory molecules54.
While the potent type I IFN response observed upon MPP8-
depletion is likely to be multifactorial, as described for the
immune response evoked upon treatment with pharmacological
inhibitors of DNA methylation42, here, we could implicate LINE-
1 RNAs and potentially LINE-1-containing transcripts to play a
causative role using LINE-1 knockdown and overexpression
experiments (see Fig. 7 for a proposed summary model).
Importantly, we also found LTRs nearby ISGs to become dere-
pressed upon HUSH-depletion suggesting that the HUSH com-
plex may control type I IFN responsiveness, as well as IFN
induction. Of note, ERV9 LTRs that we observed to be dere-
pressed have been described to act as cryptic promoters under
epigenetic regulation55. LTRs have also been shown to drive
production of novel cancer-specific antigens56.
Finally, we note that MPP8 is frequently downregulated in
cancers, which may relate to the increase in DNA damage that we
Fig. 4 MPP8-depletion results in overexpression of LINE-1s and LTRs. a ISRE-GFP reporter 293 cells were transfected with control (CTR) or
MPP8 siRNAs or dsRNA as a positive control and GFP measured on day 6. N= 5 biologically independent samples or N= 3 for the positive control. P=
0.0108 (two-tailed paired t test). Data show mean ± SD. MFI: mean fluorescent intensity. b Left: HeLa cells were harvested 4 days post shRNAs and used
for western blot for L1 ORF1 protein and alpha-Tubulin. Right: western quantification. N= 3 biologically independent samples. P= 0.0426 (one-tailed
paired t test). Data show mean ± SD. c Bubble plots showing the relative prevalence of all TEs in the genome by clade (orange) and relative abundance of
overexpressed TE families in shMPP8 samples compared to controls (blue) using RNA-seq data from Fig. 2 and the software TEtranscripts. See
Supplementary Fig. 4a for complete diagram. Monkey images drawn by lab members. d Upper panel: TE loci up or downregulated in MPP8-depleted cells
(log2 fold change >1, and p adjusted values <0.05 after Benjamini–Hochberg multiple testing correction of Wald test p-value of shMPP8/shControl from
DESeq2). See dataset 3 in Source data for all exact p values. Results are shown for loci within the stated LINE-1 families. Ns= expression not significantly
changed. Lower panel: strip plot showing HUSH-bound (orange) vs. not known to be bound (gray) LINE-1 loci with their relative expression in shMPP8
samples compared to controls. HUSH peaks defined using epic2, see Supplementary Fig. 3a, using data from ref. 33. The approximate ages of these LINE-1
families are given underneath using79. See Supplementary Fig. 4b for LTR data. The subfamily names with the highest number of upregulated loci (top) or
bound loci (bottom) are highlighted in orange. Boxes represent 1st and 3rd quartile, where the central line corresponds to the median; whiskers are ×1.5 of
the interquartile range. e Pie charts showing upregulated TE loci (left) and HUSH-bound TE loci (right) classified by family. f Median distance of
Upregulated L1s (n= 1494) or LTRs (n= 1177) to transcription start sites of upregulated ISGs (n= 204) compared to the same number of random genes or
to the median distance across 1000 randomizations. The median distance for LTRs is significantly closer than randomized genes (p= 0.001, where a one-
sided p value was calculated as (1+ no. of randomizations with a median greater than the observed value)/1000 randomizations). Boxplots as in (d) where
notches indicate the confidence interval. g Left: the L1PA1 consensus sequence (repBase) was mapped with RNA-seq reads in both strands (left y axis) or
with MORC2 ChIP and total input reads from public data33 (right y axis). Right: The number of RNA-seq reads mapping forward or reverse strands of the
L1PA1 consensus sequence were plotted for all samples. Two-tailed unpaired t test values: p= 0.0006 (forward) and p= 0.0291 (reverse). Data show
mean ± SD. h Bigwig visualization of example HUSH-bound young LINE-1 expressed bidirectionally and a HUSH-sensitive primate-conserved LINE-1
expressed in sense (i). RNA-seq track scales were all set at 50 and normalized tracks of HUSH-binding were made using data from ref. 33.
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observe in MPP8-depleted cells. Whether DNA damage is related
to IFN induction57 or caused by DNA breaks mediated by LINE-
1-encoded endonuclease47 warrants future investigation. It will
also be interesting to determine whether MPP8-depletion con-
tributes to carcinogenesis in vivo. Our results fit with a more
general emerging role for LINE-1 elements in driving IFNs and
inflammation21–24,58–60. Of note, although the cGAS/STING
pathway was not necessary for the IFN response here, it may
contribute to IFN release in vivo and could be upregulated and
more active in HUSH-depleted cells. Open questions include
uncovering exactly how LINE-1 elements are transcribed bidir-
ectionally and why, and determining whether LINE-1 dsRNA is
tethered to chromatin in control cells to mask if from
MDA5 sensing. It’s not clear if LINE-1 proteins play a role in
nucleic acid sensing of LINE-1 dsRNA. Little is known too about
how co-opted conserved LINE-1s and other TEs potentially
control innate immune genes through gene-regulatory roles and if
the HUSH complex is downregulated during physiological
immune responses. It is tempting to speculate that LINE-1 ele-
ments may play a causative role in driving autoinflammatory
diseases and may have been repurposed long ago to naturally
prime or potentiate MDA5-mediated innate immunity.
Methods
Cell culture and reagents. HEK293 WT (referred to as 293) or CRISPR/Cas9-
generated knockout 293 cells for either RIG-I, MDA5 or both and HeLa cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Thermo Fisher
Scientific) supplemented with 100 U/ml penicillin/streptomycin (Gibco, Thermo
Fisher Scientific) and 10% heat-inactivated fetal calf serum (FCS) and grown at
10% CO2 at 37 °C. Cell lines were split 1:4 every 3 days using trypsin. 293 reporter
cell lines harboring a lentivector expressing destabilized GFP under the control of
IFN-stimulated responsive elements (ISRE) or destabilized GFP under control of
an IFN-β promoter were a kind gift from Jan Rehwinkel35,36. Note that these
reporter constructs include a puromycin cassette, hence we did not use puromycin-
selection of shRNAs in these cells, which was unnecessary due to their high
transduction efficiency. Human primary foreskin fibroblasts (HFFs) were a kind
gift from Matt Reeves and early-passage cells were split 1:3. shRNAs were
puromycin-selected in HFFs. The THP-1 IFIT-2 luciferase reporter cell lines were
purchased from Invivogen and cultured according to the manufacturer’s guidelines.
These cells are WT or CRISPR/Cas9 knockout for cGAS, STING or IFNAR and
express secreted Lucia luciferase under control of a minimal IFIT2 promoter in
conjunction with 5 ISRE units. IFN-β (PeproTech) or Universal type 1 IFN
(Interferon-αA/D, PBL Assay Science) were used at 10 ng/ml or 200 U/ml,
respectively. Poly (I:C) (Invivogen) was used at 150 ng per well in a 24 well plate
and dsRNA was made by in vitro transcription61 and used at 1 µg/ml complexed
with Lipofectamine 2000 (Invitrogen, Thermo Fisher Scientific) at a 1:3 ratio
according to the manufacturer’s instructions. The reverse transcriptase inhibitors,
AZT and 3TC were used at 100 µM and 200 µM, respectively. The JAK-STAT
inhibitor Ruxolitinib (Cambridge Bioscience) was used at 2 µM, which was






























































































































































































































































Fig. 5 LINE-1s regulate the type I IFN response. a 293 reporter cells were shControl/shMPP8 treated together with the stated shRNAs against TE families
or shControl again. GFP MFI (mean fluorescence intensity) at day 6 was normalized to the shMPP8+ shControl sample that was set at 100%. N= 4
biologically independent samples, except for shL1_d-f, where n= 3 and shL1PA4, where n= 6. The control was significantly different to the shL1PA1 group
(p= 0.0172), the shL1PA4 group (0.0110) and the MOV10 group (p= 0.0265) (two-tailed paired t tests). b Groups were setup as in (a) but here
endogenous ISG expression was measured by qRT-PCR. N= 2 biologically independent experiments with technical duplicates shown. c Knockdown
efficiency was verified by qRT-PCR using global LINE-1 primers. N= 3 biologically independent experiments. A decrease in global LINE-1 expression was
detectable for shL1PA4: p= 0.0013 (L1PA2-3) and p= 0.0268 (L1PA4) (two-tailed unpaired t tests). d Venn diagram showing overlap of genes induced by
overexpression of an engineered L1PA1 reporter in RPE cells from ref. 21 (a Tet-inducible codon-optimised L1PA1 vs. Luciferase control that was induced for
3 days) and genes upregulated upon MPP8-depletion here. Of 114 genes that overlap, 49 are ISGs. Right: significance was assessed by selecting 10,000
randomizations of the same number (1830) of random genes and looking at the mean number that are shared with the L1-induced genes. P= 5.1203e−24
(hypergeometric test). e 293 reporter cells transfected with a pcDNA control or engineered L1PA1 reporter plasmid (ksCMV-101: L1PA1 subtype L1.3).
Transfection and retrotransposition verified by western blot and qRT-PCR for spliced Neomycin expression at day 4 (left and middle). N= 3 biologically
independent experiments with technical duplicates shown. Right: IFN reporter induction was measured by GFP FACS. N= 3 biologically independent
experiments. P= 0.0332 (one-tailed paired t test). All data presented in this figure show mean values ± SD.
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Fig. 6 MPP8 is frequently downregulated in cancers. a Using The Cancer Genome Atlas (TCGA) data, we selected cancers for which there were matched
control samples as well as GTEx expression data from the same tissue. MPP8 is scored here as significantly downregulated when levels are lower in the
cancer compared to both controls separately, using a two-sided Mann–Whitney rank test and correcting for multiple testing (p adjusted values were all
<0.05 for groups marked with asterisks). Adjusted p values for matched control comparisons and GTEx comparisons respectively are given here: bladder
urothelial= 2.40e−05, 1.58e−06; breast invasive= 5.40e−35, 8.79e−61; cervical & endocervica l= 3.12e−03, 2.37e−07; esophageal= 1.07e−03, 4.0e
−15; glioblastoma= 2.10e−08, 6.61e−40; liver hepatocellular= 1.31e−03, 5.57e−31; lung adeno= 1.19e−11, 9.56e−82; lung squamous cell= 2.40e−26,
1.41e−97; prostate adeno= 2.06e−11, 8.27e−31; thyroid= 1.25e−10, 9.24e−17. b Left: all cancers were divided by immune subtype based on ref. 17 and
levels of MPP8 expression were plotted. MPP8 levels were most significantly different in subtype C2 compared to normal tissue (after pairwise, two-sided t
tests between each immune subtype and normal tissue with an fdr multiple test correction: padj= 8.03e−94; C1 n= 2,066, C2 n= 2413, C3 n= 2334, C4
n= 1129, C5 n= 378, C6 n= 180 samples). Boxes represent 1st and 3rd quartile and the central line is the median. Notches indicate the confidence
interval; whiskers correspond to 1.5 of the interquartile range and outliers are depicted as diamonds. Right: features of cancers within immune subtype C2
are displayed (terms from ref. 17). c 293 reporter cells were treated with shRNAs and then either untreated or treated with etoposide (ETO) for 30min and
allowed to recover for stated times before γH2AX staining. Left: example γH2AX staining images. Middle: summary data of γH2AX foci: N= 6 biologically
independent samples. p= 0.0013 (two-tailed paired t test). Right: summary data of recovery assay. N= 4 biologically independent samples, except for the
groups, ETO and ETO/1 h, where N= 3. Two-tailed paired t test p values= 0.0303 (ETO) 0.0486 (ETO/1 h) 0.0384 (ETO/3 h) and 0.0258 (ETO/6 h).
Data show the mean ± SD. See Supplementary Fig. 6e for HeLa data.
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Western blotting. Cells were washed once in ice-cold PBS and lysed using pre-
chilled homemade Radioimmunoprecipitation assay buffer [150 mM NaCl; 1%
Triton X-100; 0.5% sodium deoxycholate; 0.1% SDS and 50 mM Tris, pH 8.0,
protease inhibitors (#539134, Calbiochem) and phosphatase inhibitor cocktail
(PhosSTOP, Roche)] for 30 min at 4 °C. Cell lysates were cleared by centrifugation
(12,000 × g, 20 mmin, 4 °C) and a fraction of lysate was used to perform a protein
quantification assay (BCA Protein Assay Kit, Novagen). Standardized lysate sam-
ples were mixed with NuPAGE LDS sample buffer (Thermo Fisher) and 5% β-
mercaptoethanol and heated at 95 °C for 5 min and then resolved on precast
NuPAGE 4–12% Bis-Tris (Invitrogen) or handcast 10% SDS-polyacrylamide gels in
tris/glycine/SDS buffer in mini-PROTEAN tanks (Biorad), followed by wet
transfers onto Polyvinylidene Difluoride (PVDF) or nitrocellulose membranes,
blocked in 5% non-fat dried milk in TBS-T (TBS, 0.1% Tween-20) and incubated
with relevant primary antibodies: anti-MPP8 (#16796-1-AP, Proteintech), anti-
TASOR/FAM208A (HPA017142, Atlas Antibodies), anti-PPHLN1 (HPA038902,
Atlas Antibodies), anti-L1 ORF1p (MABC1152, Millipore), anti-PCNA (NA03,
Calbiochem), anti-α-Tubulin (T6074, Sigma Aldrich), anti-RIG-I (D14G6, #3743,
Cell Signaling Technology), anti-MDA5 (D74E4, #5321, Cell Signaling Technol-
ogy), anti-MAVS (#3993, Cell Signaling Technology), anti-STING (D2P2F, #13647,
Cell Signaling Technology), anti-cGAS (D1D3G, #15102, Cell Signaling Technol-
ogy), anti-IFIT1 (D2X9Z, #14769, Cell Signaling Technology) and anti-ISG15 (A-5,
sc-166712, Santa Cruz Biotechnology). All secondary antibodies were horseradish
peroxidase-conjugated (GE healthcare) and membranes were developed using ECL
kits (ECL, Prime or Select kits from Amersham). Source Data are available with
original blots.
shRNA lentiviral vectors and transduction. Hairpin sequences were designed
against LINE-1 integrants (using the 5′UTR or ORF1 or ORF2 sequence) known to
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Fig. 7 Proposed model. Inactivation of the HUSH component MPP8 leads to increased expression of bidirectionally-transcribed full-length young LINE-1s
(L1PA1 and L1PA2), as well as primate-conserved LINE-1s with potential co-opted roles in gene regulation, (some enriched in long non-coding RNAs).
Nucleic acid sensing ensues through dsRNA sensors MDA5 and RIG-I, leading to MAVS signaling and activation and secretion of type I IFNs. IFN-α/β then
act on the same cells or bystander cells to mediate induction of IFN-stimulated genes through JAK-STAT signaling. MPP8-depletion is also accompanied by
DNA damage and is a factor commonly downregulated in cancers, where its decreased mRNA expression is associated with a dominant IFN immune
subtype signature.
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designer website (http://bioinfo.clontech.com/rnaidesigner/) and verified in silico
before cloning. Hairpin primers were annealed and then cloned into an shRNA
vector15 at BamHI-EcoRI sites and the products were checked by verification of an
introduced restriction site and by sequencing. VSV-G-pseudotyped lentiviral vec-
tors were produced by co-transfecting 293T cells in 10 cm plates with 1.5 µg of the
shRNA plasmid, 1 µg p8.91 and 1 µg pMDG2 encoding VSV-G. Media was
changed 1 day post transfection and supernatant harvested 48 h post-transfection
and concentrated via ultracentrifugation. Puromycin selection was performed
3 days post transduction overnight or until control cells died. For 293 and HeLa
cells, puromycin selection was not necessary and for this reason, dual transductions
were performed in 293 cells.
CRISPR/Cas9 generation of RIG-I-like receptor knockout HEK293 cell lines.
RIG-I, MDA5, and RIG-I/MDA5 knockout 293 cells were generated by
CRISPR–Cas9-mediated genome engineering. Using the CRISPR design tool provided
by the Zhang lab (www.genome-engineering.org) several guide sequences were
selected in human DHX58 (encoding RIG-I) and IFIH1 (encoding MDA5) (Sup-
plementary Table 1). Appropriate oligonucleotides corresponding to these guide
sequences were cloned into the BbsI site of pX459 (Addgene 62988), a bicistronic
expression vector encoding both Cas9 and the single-guide RNA, according to the
cloning protocol provided by the aforementioned website. Plasmid pX459 was
obtained from the lab of Dr. Feng Zhang via Addgene (plasmid 62988)62. 293 cells
were transfected in a 6-well plate using 1 μg pX459 per well using Lipofectamine
2000 (Life Technologies) according to the manufacturer’s instructions. Twenty-
four hours post-transfection, cells were treated for 24 h with 1 μg/ml puromycin to
remove untransfected cells and subsequently replated at limiting dilution in order
to pick individual colonies. Knockout of RIG-I and/or MDA5 was verified by
amplification and sequencing of the genomic region surrounding the CRISPR
target site, immunoblotting, and in a luciferase-based transfection reporter assay, in
which luciferase activity is controlled by the IFN-β promoter, using selective RIG-I
and MDA5 agonists.
RNA extraction and quantification. Total RNA was extracted using RNeasy
Micro kit columns (Qiagen) and DNase treated according to the manufacturer’s
instructions (Ambion AM1907). 500 ng of RNA was reverse transcribed using
random primers and SuperScript II Reverse Transcriptase (Thermo Fisher Scien-
tific). Control reactions were always performed in the absence of reverse tran-
scriptase and used for qRT-PCR in parallel to cDNA to verify there was no DNA
remaining. cDNA was diluted in nuclease-free water, and gene expression levels
were quantified using quantitative reverse transcription PCR (qRT-PCR) using an
ABI 7500 Real Time PCR System (Applied Biosystems). SYBR green Fast PCR
mastermix (Life Technologies) was used. CT values for the test genes were nor-
malized against those of Gapdh or B2M using the –ΔΔCt method to calculate fold
change. See Supplementary Table 2 for primer sequences, which includes a
breakdown of TE primer hits to TE subfamilies.
Flow cytometry. Cells were trypsinized and harvested in media and centrifuged
and then fixed in 1% paraformaldehyde for 10 min (or unfixed) and washed in PBS,
resuspended in PBS and run on a BD FACSCalibur or LSRFortessa Flow Cytometer
acquiring 10 000 cells per sample to meet statistical robustness using BD CellQuest
or FACSDiva software. Intracellular FACS34 was performed in 293 cells (not
reporter cells) using the dsRNA-specific antibodies, J2 and K1 (from English and
Scientific Consulting Hungary, SCICONS) or an isotype control antibody (mouse
IgG2a, Santa cruz sc-3878), with a secondary Alexa Fluor 488 goat anti-mouse IgG
(ThermoFisher). We verified the antibodies to recognize dsRNA by intracellular
FACS after transfection of dsRNA. ShortCut RNase III was used for long dsRNA
digestion (NEB). Data were analyzed using FlowJo (Tree Star version 10.3.0). The
flow cytometry gating strategy, which involved gating on live cells and then on GFP
positive cells (or dsRNA-positive cells) using the negative control sample is shown
in Supplementary Fig. 7.
Luciferase assays. 293T cells were plated at 105 cells/ml in 12 well plates, 1 ml per
well and co-transfected with 500 ng KZNFs, 50 ng SVA or L1PA4 luciferase
reporter plasmids (kind gift from David Haussler40) and 5 ng pRT-TK Renilla
control plasmid. Cells were then lysed and luciferase measured 48 h later using the
Dual Luciferase assay kit (Promega, E1910) and a Glomax 96 microplate Lumin-
ometer (Promega) using the Dual Glow Programme according to the manu-
facturer’s guidelines.
Interferon-β ELISA. An ELISA kit precoated with an antibody against human
IFN-β (VeriKine Human IFN Beta ELISA Kit, 41410 by PBL) was used according
to the manufacturers’ instructions. Absorbance measurements were taken at
450 nm using a Multiskan FC Microplate Photometer and SkanIT Software.
Optical densities were plotted using a 4-parameter fit for the standard curve and
this was used to determine the IFN-β concentrations of test samples.
Engineered LINE-1 reporter constructs. RNA-sequencing data were employed
from ref. 21, in which a Tet-inducible codon-optimised L1PA1 (ORFeus) was
induced in RPE cells using doxycycline treatment for 3 days. vs. an induced luci-
ferase control. A list of genes that were significantly upregulated (>10 fold with p
adjusted values <0.05) was obtained (for data access, see: https://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE119999) and the overlap of this list compared to
genes upregulated in this study (HFF cells) upon depletion of MPP8. For experi-
ments in which we overexpressed engineered LINE-1, we used a full-length active
L1PA1 construct expressed from a CMV promoter (ksCMV-101/L1.3, which is not
codon-optimized, kind gift from Jose Garcia-Perez). This construct contains a
neomycin resistance cassette, inserted within the 3′UTR, in the opposite direction,
interrupted by an intron. Expression of the neomycin gene depends on tran-
scription, splicing, reverse transcription and integration. Engineered L1PA1 was
transfecting into 293 ISRE-GFP reporter cells vs. pcDNA control and 4 days later,
L1 ORF1 protein, spliced Neomycin expression and ISRE-GFP reporter induction
were measured.
Total RNA-sequencing and analysis. The RNA was quality checked on a 4200
Tapestation using the RNA ScreenTape assay (Agilent Technologies, Wokingham,
UK) and the RNA concentration measured using a Qubit RNA Broad Range kit
(Life Technologies, Paisley, UK). Total RNA samples were then processed using
KAPA’s stranded RNA HyperPrep RiboErase kit using an input of 500 ng per
sample. Samples were sequenced on a NextSeq 500 instrument (Illumina Cam-
bridge, Chesterford, UK) after pooling libraries in equimolar quantities, using a 2x
151 bp paired-end run, resulting in over 15 million reads per sample. Illumina’ s
bcl2fastq Conversion Software was used to demultiplex data and generate fastq
files. Fastq files were checked for quality with FastQC v.0.11.863 and TrimGalore
v0.4.164 was used to remove adaptors only. Reads trimmed for adaptors were
aligned to the human genome USCS build hg38 using Tophat 2.1.065 and Gencode
v3066 gene annotations (https://www.gencodegenes.org/human/release_30.html).
The number of read counts per gene was calculated using HTSeq-Count67, the
BioConductor package DESeq268 was used to estimate differential expression of
genes across conditions, and the Approximate Posterior Estimation method69 was
used to shrink the logarithmic fold change. As per the default behavior of DESeq2,
p-values were adjusted for multiple testing with the Benjamini–Hochberg false-
discovery-rate (FDR) procedure. Genes were considered as significantly differen-
tially expressed when the adjusted p-values were <0.05, and where the log2 of the
fold change was >1 for upregulated or < (−1) for downregulated genes. BiomaRt70
was used to convert gene identifiers and gene set enrichment analysis, based on
rank derived from the abs(log2FC)*(-log10(pvalue)) and the Hallmark Gene Set
Collection from MSigDB71,72 (https://www.gsea-msigdb.org/gsea/msigdb/genesets.
jsp? collection=H), was performed with the fgsea package 1.8.073 and gage 2.32.0
from R Bioconductor. We defined the list of ISGs before15 by employing http://
www.interferome.org and selecting genes upregulated by 10-fold upon IFN treat-
ment. Enrichment of Reactome pathways (https://reactome.org/) within gene
subsets was performed with clusterProfiler74. For analysis of individual TE inte-
grants, TopHat2 alignments were used to obtain the number of unique reads
mapping to individual TE loci using HTSeq-count and custom-made annotation
files where each TE locus was given a unique identifier. To reduce the number of
features provided as input for the analysis, TE loci with less than 20 counts across
all 21 samples were filtered out before submitting the files with the counts per TE
loci to DESeq2. Differential expression analysis was performed as for genes and
including gene counts. Venn diagrams were made with VennDiagram 1.6.20.
For analysis of TE family expression, the TEcounts tool of TEtranscripts39 was
used to obtain TE counts, followed by differential expression analysis using
DESeq2. TE families were considered to be significantly differentially expressed
when the adjusted p-values were <0.05, and where the log2 of the fold change was
>1 for upregulated families and <−1 for downregulated families. HUSH binding to
TEs was assessed using public data33 found here: https://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE95374.
Expression coverage tracks were generated with the genomecov tool from
bedtools75, scaled by library size, where read pairs were separated by their strand of
origin and individual replicates were merged for knockdown and control samples
of biological triplicates from the same batch. Different vector preparations
(produced at different times) were used for each biological replicate. bigWig tracks
were visualized using the Integrative Genomics Viewer76. For identification of
bidirectional transcription, genome-wide coverage was calculated for 500 bp bins,
using the above-mentioned BigWig tracks. A bin was considered to be expressed
from a given strand if its mean expression was above the value equivalent to the
85th percentile of all bins with an expression value greater than 0. Bins that passed
the threshold for both strands were considered to be bidirectionally transcribed.
Bidirectionally transcribed bins were merged into larger intervals when found
adjacent to each other using bedtools merge. We then intersected results with
RepeatMasker annotation (http://www.repeatmasker.org/) to uncover bidirectional
TEs, with the top hit being L1PA1.
For the TEs with the largest number of loci within bidirectionally-transcribed
bins (L1PA1 and L1PA2), we retrieved consensus sequences from RepBase (https://
www.girinst.org/repbase/) and aligned all reads to each individual reference (full-
length L1PA1, full-length L1PA2, assembled from RepBase fragments: L1P1_5end,
L1P1_orf2, L1PA2_3end, or the sequence of a full-length L1PA2 previously
identified to be MPP8-bound33, coordinates: chr1: 207733982-207734498). Depth
across the different sequences was calculated using samtools depth, normalized
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using size factors calculated for the entire library. Total number of reads mapping
to a reference was obtained with the samtools flagstat command.
Each TE family in the human genome was assigned a taxonomy level using
information from Dfam (https://dfam.org/). The relative abundance per taxonomy
level of all families in the genome or upregulated families only was visualized in a
phylogenetic tree obtained from the NCBI Taxonomy Database (https://www.ncbi.
nlm.nih.gov/ Taxonomy/Browser/wwwtax.cgi) using the ETE Toolkit77.
The distance between the TE subsets (L1s or LTRs upregulated in
shMPP8 samples compared to shControl samples) and the transcription start sites
(TSSs) of IFN response genes was calculated using the pybedtools closest function
with RepeatMasker annotation and TSSs retrieved using biomaRt (https://www.
ensembl.org/biomart/martview/). Random subsets of genes were generated within
python. Total RNA-sequencing data can be found here: https://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE135765.
The cancer genome atlas (TCGA) and GTEx analysis. Phenotype data were
downloaded from https://xenabrowser.net/ for the TCGA TARGET GTex cohort78.
The phenotype table was manually curated to include only cancer types that had both
a matched normal tissue from TCGA and an independent normal tissue from GTex.
The TcgaTargetGtex_RSEM_Hugo_norm_count dataset was queried using the xena-
Python python API. Differences in expression between cancer and control samples
were statistically assessed using a Mann–Whitney U test followed by an FDR multiple
test correction in python. The results shown in Fig. 6 are in part based upon data
generated by the TCGA research network (https://www.cancer.gov/tcga)44, The
Genotype-Tissue Expression (GTEx) Project45 and The TARGET Program
(https://ocg.cancer.gov/programs/target)78. The Genotype-Tissue Expression
(GTEx) Project was supported by the Common Fund of the Office of the Director
of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH,
and NINDS; the data used for the analyses described in this manuscript were
obtained from dbGaP accession number phs000424.vN.pN on 01/09/2019. Raw
data from Synapse ICGC-TCGA Whole Genome Pan-Cancer Analysis project
(https://www.synapse.org/#!Synapse:syn2351328/wiki/62351, https://www.synapse.
org/#!Synapse:syn11288411) was downloaded and visualised using UCSC Xena




net. Source data are available with RNA-seq datasets.
DNA damage. HEK293 or HeLa cells were transduced with shRNAs and then 2 ×
104 cells plated per well two days later in 96 well Cell-carrier optical plates.
4–6 days post transduction, cells were treated with 60 μM or 30 μM etoposide for
30 min or left untreated. For recovery studies, etoposide-treated cells were washed
2× in PBS and new media was added for the indicated times. Cells were fixed with
3% paraformaldehyde, quenched with 50 mM NH4Cl and permeabilised with 0.3%
Triton X-100 in PBS. Blocking was performed in PBS containing 1% FCS before
washing and staining with the γH2AX primary antibody for 1 hour and then
washed and stained for 1 h with a Red Alexa Fluor-conjugated secondary antibody.
Cells were then washed and stained with DAPI. Images were acquired and analyzed
using a Hermes WiScan-automated system (IDEA Bio-Medical Ltd. Rehovot,
Israel), using ImageJ software.
Statistical analysis. All data are presented with error bars showing standard
deviation (SD) or standard error of the mean (SEM), where stated and statistical
significance was assessed using two tailed, unpaired Student t tests, or other sta-
tistical tests where stated (see figure legends for details) employing GraphPad
prism. The number of biological replicates is stated in the figure legends and
technical replicates where relevant: for flow cytometry technical replicates were
10,000 events. A P-value of <0.05 was considered statistically significant (****p <
0.0001, ***p < 0.001, **p < 0.01 and *p < 0.05).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Total RNA-sequencing data are available on the NCBI Gene Expression Omnibus
database (accession number, GSE135765) and other data are included in this article and
its supplementary information files. Accession numbers for the publicly-available data
are: GSE95374 for ChIP-sequencing data on the HUSH complex, and GSE119999 for
RNA-sequencing data on cells expressing engineered LINE-1s. All data is available from
the authors upon reasonable request. Source data are provided with this paper.
Code availability
Code is deposited in the following open source repository (https://github.com/regmdr/
HUSH_analysis) and detailed in the methods and all code can be retrieved by contacting
the corresponding author.
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